Related Experiment Video
Updated: Jun 22, 2025

08:14
Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting
Published on: September 25, 2012
18.2K
Multiparameter quantitative analyses of diagnostic cells in brain tissues from tuberous sclerosis complex
Jerome S Arceneaux1, Asa A Brockman2, Rohit Khurana2
1Department of Biochemistry, Cancer Biology, Neuroscience, and Pharmacology, Meharry Medical College, Nashville, Tennessee, USA.
Cytometry. Part B, Clinical Cytometry
|July 2, 2024
Summary
We developed BAIDEN, a machine learning tool to identify balloon cells (BCs) in tuberous sclerosis complex (TSC) brain tissue using high-dimensional imaging. This advances molecular characterization of TSC and aids BC identification in research models.
Area of Science:
- Biomedical imaging
- Computational pathology
- Molecular diagnostics
Background:
- Tuberous sclerosis complex (TSC) is a genetic disorder characterized by benign tumor growth.
- Balloon cells (BCs) are diagnostic markers in TSC brain tissue, but their molecular identity is not fully understood.
- Accurate BC identification is crucial for research models and understanding TSC pathogenesis.
Purpose of the Study:
- To develop a computational pipeline for automated BC identification in TSC.
- To characterize BCs molecularly using high-dimensional imaging mass cytometry (IMC).
- To establish a workflow for analyzing cellular features in human tissues.
Main Methods:
- Development of a machine learning pipeline (BAlloon IDENtifier; BAIDEN) for BC detection.
- Application of a 36-antibody panel with IMC for high-dimensional single-cell analysis.
- Integration of BAIDEN with IMC data and analysis pipelines for comprehensive BC profiling.
Main Results:
- Successful prospective identification of BCs in TSC brain tissue sections using a novel computational approach.
- Exploration of multiple protein markers to define conserved BC features across patient samples.
- Characterization of BC abundance, structure, and signaling activity within the TSC context.
Conclusions:
- High-dimensional imaging combined with machine learning offers powerful tools for characterizing rare cell types in human diseases.
- The developed workflow provides a framework for molecularly defining diagnostic cells in complex disorders like TSC.
- This approach facilitates the study of BCs in both clinical samples and experimental models, advancing TSC research.

